Polyrizon (PLRZ) stock dove on Tuesday after the biotech company announced plans for a reverse stock split. This reverse split will see the company consolidate six shares of PLRZ stock into a single share. This will drop the company’s total outstanding shares from 6,250,053 to 1,041,676.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Polyrizon noted that the reverse stock split is set to go into effect when markets open on November 28, 2025. The shares will continue to trade under the PLRZ stock ticker, with the new CUSIP number being M79549206. The company also noted there will be no fractional shares as a result of this reverse split and that it will instead round partial shares to the nearest whole share.
Polyrizon didn’t provide a reason for the reverse stock split, but traders will note that the company has been flirting with delisting this year. It received a warning in March 2025 concerning its Series A warrants and the dilution of its shares. It’s also worth keeping in mind that PLRZ stock has fallen below the $1 minimum bid price required to maintain a listing on the Nasdaq.
Polyrizon Stock Movement Today
Polyrizon stock was down 11.78% in pre-market trading on Tuesday, following a 6.94% rally yesterday. The shares have dropped 99.87% year-to-date and 99.71% over the past 12 months.
Today’s reverse split news saw some 203,000 shares change hands as of this writing, compared to a three-month daily average of about 233,000 units.
While the reverse stock split won’t change Polyrizon’s market capitalization, that doesn’t mean it won’t have a negative effect on the company’s shares. These types of splits, combined with the reasons for them, can often lower investor morale. This appears to be what’s going on with PLRZ stock today.
